Lopinavir/ritonavirAcute hepatocellular hepatitis following off-label use in COVID-19: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1828卷 / 1期

关键词：

D O I：

10.1007/s40278-020-85378-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：302 / 302

相关论文

共 50 条

[1] Lopinavir/ritonavirAcute hepatitis following off-label use
Reactions Weekly, 2024, 2009 (1) : 354 - 354
[2] Lopinavir/ritonavirAcute kidney injury following off-label use: 8 case reports
Reactions Weekly, 2020, 1834 (1) : 154 - 154
[3] Hydroxychloroquine/lopinavir/ritonavirDrug ineffectiveness following off-label use in COVID-19 infection: case report
Reactions Weekly, 2022, 1905 (1) : 239 - 239
[4] Azithromycin/lopinavir/ritonavirAcute kidney injury following off label use: case report
Reactions Weekly, 2021, 1838 (1) : 93 - 93
[5] Lopinavir/ritonavirVarious toxicities following off-label use in COVID-19: 4 case reports
Reactions Weekly, 2021, 1843 (1) : 230 - 230
[6] Lopinavir/ritonavirHyperlipidaemia following off-label use: case report
Reactions Weekly, 2020, 1828 (1) : 303 - 303
[7] Lopinavir/ritonavirBradyarrhythmia following an off-label use : case report
Reactions Weekly, 2020, 1832 (1) : 186 - 186
[8] Lopinavir/ritonavirMaculopapular rash following off-label use: case report
Reactions Weekly, 2020, 1824 (1) : 179 - 179
[9] Lopinavir/ritonavirLichen planus following off-label use: case report
Reactions Weekly, 2021, 1849 (1) : 271 - 271
[10] Lopinavir/ritonavirHepatic cytolysis following off-label use: case report
Reactions Weekly, 2021, 1837 (1) : 399 - 399

← 1 2 3 4 5 →